To investigate the anticancer effects and potential mechanism of afatinib in pancreatic carcinoma (PC).
Capan-1 cells were treated with 0.5, 1.0, 2.0 and 4.0 μmol/L afatinib for 24 h, and normal cultured cells were set as control group. Capan-1 cells were transfected with maternally expressed gene (MEG)3 overexpressed plasmid (pcDNA-MEG3) and empty loaded plasmid (pcDNA) for 48 h, respectively, which were set as pcDNA-MEG3 group and pcDNA group. Capan-1 cells transfected with MEG3 small interfering RNA (si-MEG3) were treated with 4.0 μmol/L afatinib for 24 h as 4.0 μmol/L afatinib+si-MEG3 group and 4.0 μmol/L afatinib+negative control (NC) group. Flow cytometry was used to detect cell cycle distribution. Transwell assay was used to detect cell migration and invasion. Quantitative reverse transcriptase-mediated polymerase chain reaction (qRT-PCR) was used to measure the expression of MEG3. The expressions of Cyclin D1, matrix metalloproteinase (MMP)2 and MMP9 were determined by western blotting.
Compared with the control group, Cyclin D1 protein expression, S phase cell proportion, migration and invasion number of Capan-1 cells, MMP2 and MMP9 protein expression decreased, G0/G1 phase cell proportion increased, MEG3 expression level of Capan-1 cells increased in afatinib group. The differences were statistically significant (P<0.05). Compared with human pancreatic ductal epithelial cells, MEG3 expression level in Capan-1 cells was decreased (P<0.05). Compared with the pcDNA group, MEG3 expression and the proportion of G0/G1 phase cells in Capan-1 cells in pcDNA-MEG3 group were increased, while the proportion of S phase cells, the number of cell migration and invasion, and the expression of Cyclin D1, MMP2 and MMP9 protein were decreased, with statistical significance (P<0.05). Compared with 4.0 μmol/L Afatinib+si-NC group, MEG3 expression and G0/G1 phase of Capan-1 cells in 4.0 μmol/L afatinib+si-MEG3 group were significantly decreased. The proportion of cells in S phase, the number of cell migration and invasion, and the protein expressions of Cyclin D1, MMP2 and MMP9 were significantly increased, with statistical significance (P<0.05).
Afatinib can inhibit Capan-1 proliferation, migration and invasion of pancreatic cancer cells by up-regulating MEG3 expression.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |